Abstracts tagged "CHIP"

Abstract Number: 0806 • ACR Convergence 2021
Coping with Recent-onset Rheumatoid Arthritis (RA): Validation of the Coping with Health Injuries and Problems (CHIP) Questionnaire in a Longitudinal Cohort
Zafer Alman¹, Gilles Boire², Nathalie Carrier³, Ariel Masetto², Artur deBrum Fernandes⁴, Patrick Liang², Patricia L Dobkin⁵, Allard-Chamard Hugues⁶ and Sophie Roux⁷, ¹Cerrahpasa Faculty of Medicine, Istambul, Turkey, ²Universite de Sherbrooke, Sherbrooke, QC, Canada, ³CIUSSS de l'Estrie - CHUS, Sherbrooke, QC, Canada, ⁴Universite De Sherbrooke, Fleurimont, QC, Canada, ⁵McGill University, Montréal, QC, Canada, ⁶Universit de Sherbrooke, Sherbrooke, QC, Canada, ⁷Université de Sherbrooke, Sherbrooke, QC, Canada
Background/Purpose: Receiving a Rheumatoid Arthritis (RA) diagnosis presents a significant health stressor. Given that little is known about how patients cope with it, we aimed…
Abstract Number: 0807 • ACR Convergence 2021
Baseline Coping Strategies as Predictors of Outcomes in Patients with Early-onset Rheumatoid Arthritis (RA)
Zafer Akman¹, Gilles Boire², Nathalie Carrier³, Sophie Roux⁴, Ariel Masetto², Artur deBrum Fernandes⁵, Patrick Liang², Patricia L Dobkin⁶ and Allard-Chamard Hugues⁷, ¹Istanbul University Cerrahpasa, İstanbul, Turkey, ²Universite de Sherbrooke, Sherbrooke, QC, Canada, ³CIUSSS de l'Estrie - CHUS, Sherbrooke, QC, Canada, ⁴Université de Sherbrooke, Sherbrooke, QC, Canada, ⁵Universite De Sherbrooke, Fleurimont, QC, Canada, ⁶McGill University, Montréal, QC, Canada, ⁷Universit de Sherbrooke, Sherbrooke, QC, Canada
Background/Purpose: Patients recently diagnosed with RA employ various coping strategies. We aimed to describe these strategies over time and determine if specific strategies impacted patient…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].